Literature DB >> 25482732

Overexpression of CX3CR1 is associated with cellular metastasis, proliferation and survival in gastric cancer.

Lu-Min Wei1, Shan Cao1, Wei-Dong Yu1, Yu-Lan Liu1, Jing-Tong Wang1.   

Abstract

The CX3CR1/CX3CL1 axis is involved in the metastasis and prognosis of many types of cancer; however, whether CX3CR1 is expressed in gastric cancer cells and whether it participates in gastric cancer metastasis remain unknown. We investigated the expression of CX3CR1 in gastric cancer tissues and non‑neoplastic gastric tissues in vivo and in gastric cancer cell lines and a gastric epithelial cell line in vitro, and then the functional roles of CX3CR1 in cellular metastasis, proliferation and survival were explored. We observed that CX3CR1 was highly expressed in gastric cancer tissues in vivo and was related to lymph node metastasis, higher clinical TNM stage and larger tumor size. In vitro, CX3CR1 overexpression promoted gastric cancer cell migration, invasion, proliferation and survival. Additionally, different from several chemokine receptors, CX3CR1 was also expressed in non-neoplastic gastric tissues and in gastric epithelial cells and played a functional role in vitro. Notably, gastric cancer tissues expressed higher CX3CR1 compared with that in the non-neoplastic gastric tissues in vivo, while in vitro, CX3CR1 expresssion in the gastric cancer cell lines was equivalent or significantly lower than that in the gastric epithelial cell line, which suggests that the high expression of CX3CR1 in gastric cancer in vivo might be induced, not constitutive. Altogether, our findings suggest that on the one hand overexpression of CX3CR1 promoted gastric cancer metastasis, proliferation and survival; on the other hand, appropriate expression of CX3CR1 in normal gastric tissues may play a physiological role in tissue remodeling after injury and/or epithelial renewal. Additionally, the tumor microenvironment may play an important role in the high expression of CX3CR1 in gastric cancer cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25482732     DOI: 10.3892/or.2014.3645

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  8 in total

Review 1.  Chemokine Receptor Antagonists: Role in Oncology.

Authors:  Sean Kraus; Thomas Kolman; Austin Yeung; Dustin Deming
Journal:  Curr Oncol Rep       Date:  2021-09-04       Impact factor: 5.075

2.  miRNA-296-3p modulates chemosensitivity of lung cancer cells by targeting CX3CR1.

Authors:  Wen Luo; Yuanlong Lin; Shanshan Meng; Yuening Guo; Jiawen Zhang; Wei Zhang
Journal:  Am J Transl Res       Date:  2016-04-15       Impact factor: 4.060

3.  Use of signals of positive and negative selection to distinguish cancer genes and passenger genes.

Authors:  László Bányai; Maria Trexler; Krisztina Kerekes; Orsolya Csuka; László Patthy
Journal:  Elife       Date:  2021-01-11       Impact factor: 8.140

4.  CX3CL1 involves in breast cancer metastasizing to the spine via the Src/FAK signaling pathway.

Authors:  Yun Liang; Lei Yi; Peng Liu; Libo Jiang; Houlei Wang; Annan Hu; Chi Sun; Jian Dong
Journal:  J Cancer       Date:  2018-09-08       Impact factor: 4.207

5.  Lymph-circulating tumor cells show distinct properties to blood-circulating tumor cells and are efficient metastatic precursors.

Authors:  Sulma I Mohammed; Odalys Torres-Luquis; Elwood Walls; Frank Lloyd
Journal:  Mol Oncol       Date:  2019-05-23       Impact factor: 6.603

6.  Tumor-Draining Lymph Secretome En Route to the Regional Lymph Node in Breast Cancer Metastasis.

Authors:  Sulma I Mohammed; Odalys Torres-Luquis; Weidong Zhou; Nadia Attalah Lanman; Virginia Espina; Lance Liotta
Journal:  Breast Cancer (Dove Med Press)       Date:  2020-03-25

7.  CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.

Authors:  Yuanyi Yue; Qiang Zhang; Zhengrong Sun
Journal:  Front Immunol       Date:  2022-01-24       Impact factor: 7.561

Review 8.  Fractalkine/CX3CL1 in Neoplastic Processes.

Authors:  Jan Korbecki; Donata Simińska; Klaudyna Kojder; Szymon Grochans; Izabela Gutowska; Dariusz Chlubek; Irena Baranowska-Bosiacka
Journal:  Int J Mol Sci       Date:  2020-05-25       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.